Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia
Open Access
- 19 January 2021
- Vol. 11 (1), e040182
- https://doi.org/10.1136/bmjopen-2020-040182
Abstract
Objective Hyperbilirubinemia is one of the most common clinical symptoms in newborns. To improve patient outcomes, evidence-based and implementable guidelines are required. However, clinical guidelines may vary in quality, criteria and recommendations among regions and countries. In this study, we aimed to systematically assess the quality of guidelines using the Appraisal of Guidelines for Research & Evaluation (AGREE)-II instrument and summarise the specific recommendations for neonatal hyperbilirubinemia in order to provide suggestions for future guideline development. Design Systematic review. Interventions We searched the PubMed, Embase, Medline and guideline databases for relevant articles on 10 April 2020. The studies were screened by two independent reviewers according to our inclusion criteria. Two reviewers independently extracted the descriptive data. Four appraisers assessed the guidelines using the AGREE-II instrument. Results Our systematic review appraised 12 clinical practice guidelines for the diagnosis and management of neonatal hyperbilirubinemia. The 12 guidelines achieved an average score of 36%–89%. The guidelines received the highest scores for clarity of presentation and lowest scores for rigour of development. Most recommendations for diagnosis were relatively consistent, but recommendations regarding risk factors, the initiating threshold of treatment and pharmacotherapy varied. Conclusions Our study revealed that current guidelines vary in the quality of the developing process and are inconsistent with regards to recommendations. Future guidelines should afford more attention to the quality of methodologies in guideline development, and more qualified evidence is needed to standardise the initiating threshold of treatment for neonatal hyperbilirubinemia.Funding Information
- the Grant of clinical discipline program (Neonatology) from the Ministry of Health of China (1311200003303)
- the grants from the Science and Technology Bureau of Sichuan Province (2020YJ0236, 2020YFS0041)
- the National Science Foundation of China (No. 81630038, 81971433)
- the Grants from Ministry of Education of China (IRT0935)
This publication has 29 references indexed in Scilit:
- Whole home exercise intervention for depression in older care home residents (the OPERA study): a process evaluationBMC Medicine, 2014
- Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancerBMC Medicine, 2013
- Predischarge Screening for Severe Neonatal Hyperbilirubinemia Identifies Infants Who Need PhototherapyThe Journal of Pediatrics, 2013
- Screening and Follow-Up of Living Kidney Donors: A Systematic Review of Clinical Practice GuidelinesTransplantation, 2011
- The updating of clinical practice guidelines: insights from an international surveyImplementation Science, 2011
- Peripheral Blood Sampling for the Detection of Allograft Rejection: Biomarker Identification and ValidationTransplantation, 2011
- National guidelines for treatment of jaundice in the newbornActa Paediatrica, 2011
- The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studiesBMJ Quality & Safety, 2010
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010
- Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of GestationPediatrics, 2004